Secure payment on i-micronews Contact Yole Développement for I Micronews reports

RSS I-micronewsYole Dévelopement on TwitterYole Développement on Google +LinkedIn Yole pageSlideshare Yole Développement I-Micronews

MedTech

Biocept filed a preliminary prospectus with the US Securities and Exchange Commission for an offering of $10 million in shares of its common stock with attached warrants to purchase additional shares. The company has not yet priced the offering but said that each stock share will be coupled with a warrant to purchase one additional share with an exercise price not less than 100 percent of the last reported sale price of the firm's common stock on the trading day immediately preceding the pricing of the offering.

Read more ...

Biocartis NV (the 'Company' or 'Biocartis'), an innovative molecular diagnostics company, announces it has entered into an agreement with AstraZeneca, a global science-led biopharmaceutical company , aimed at obtaining faster lung cancer molecular diagnostic biomarker results in Europe.

Read more ...

Accula RSV test FDA cleared for both children and adults. Mesa Biotech is a privately held, molecular diagnostic company that has developed an affordable and easy to operate PCR (polymerase chain reaction) testing platform designed specifically for point-of-care (POC) infectious disease diagnosis.

Read more ...

K’Watch Glucose, world first CGM Smartwatch, will make CGM painless and totally discreet. PKvitality, a bio-wearable medical technology company focused on the development of a minimally invasive smartwatch to measure glucose, announces that K’Watch Glucose will monitor glucose level on a continuous basis.

Read more ...

A daring effort is under way to create the first children whose DNA has been tailored using gene editing. When Chinese researchers first edited the genes of a human embryo in a lab dish in 2015, it sparked global outcry and pleas from scientists not to make a baby using the technology, at least for the present.

Read more ...

SimplexaTM GBS Direct molecular assay enables in vitro detection of Group B Streptococcus. DiaSorin Molecular has announced that the FDA has cleared its new Simplexa GBS Direct assay for diagnostic use. Designed for use on the LIAISON® MDX instrument, the highly sensitive assay enables qualitative detection of Group B Streptococcus (GBS) nucleic acid from 18- to 24-hour Lim broth enrichments of vaginal/rectal specimen swabs obtained from antepartum women.

Read more ...

Upcoming Events

No events

Presentation

Micromachined Ultrasound Technologies: An Overview of Emerging Trends and Applications
Discover the presentation held by Jérôme Mouly, Senior Technology & Market Analyst, Inkjet...
CRISPR Technology & Market Overview: challenges, market competition landscape and strategic opportunities
Discover the presentation held by Asma Siari, Technology & Market Analyst in Biotechnologies...
Birth of a Future Giant: Zoom on the Chinese Microfluidics Industry
Discover the presentation held by Sébastien Clerc, Market & Technology Analyst, Microfluidi...

Access to all our presentations